Latest news
Loading news…
Celenex
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Columbus, Ohio, United States 1-10 employees For Profit
Celenex is developing treatments for rare genetic diseases.
Celenex was acquired by Amicus Therapeutics in 2018 for $452M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- IT spend
- $8.82M
Company Info
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- HQ
- Columbus, Ohio, United States
- Region
- Great Lakes, Midwestern US
- Exit date
- Sep 20, 2018
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.4
- Trend (30d)
- -1.3
- Trend (90d)
- -1.2
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Celenex
Loading news…
FAQs about Celenex
People who checked this page also checked these
Browse the full Acquirezy directory.